BioLineRx BLRX
NASDAQ BLRX
$2.32 -0.02 (-0.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioLineRx (BLRX) Non Operating Investment Income (2024 - 2026)

Updated

BioLineRx's Non Operating Investment Income came in at -$4.34 million for the quarter ended Jun 30, 2026, compared with -$3.94 million a year earlier.

Analysis

BioLineRx (BLRX) Non Operating Investment Income (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Non Operating Investment Income of -$11.84 million.

  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Non Operating Investment Income since the quarter ended Sep 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioLineRx 6.06 Bn 6.06 Bn 235,000.00 -4.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.34 Mn
Mar 31, 2026 -2.59 Mn
Sep 30, 2025 -977,000.00
Jun 30, 2025 -3.94 Mn
Mar 31, 2025 5.13 Mn
Sep 30, 2024 -5.82 Mn
Jun 30, 2024 484,000.00
Mar 31, 2024 -696,000.00
API Access

BioLineRx Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BLRX&period=max&api_key=YOUR_API_KEY